MNK Proteins as Therapeutic Targets in Leukemia
Candice Mazewski,1,2 Leonidas C Platanias1– 3 1Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA; 2Division of Hematology–Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; 3Department of Medicine, Jesse Brown Veterans Affairs Med...
Main Authors: | Mazewski C, Platanias LC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-04-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/mnk-proteins-as-therapeutic-targets-in-leukemia-peer-reviewed-fulltext-article-OTT |
Similar Items
-
The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma
by: Sathyen A. Prabhu, et al.
Published: (2020-06-01) -
Controlling TIME: How MNK Kinases Function to Shape Tumor Immunity
by: Thao N.D. Pham, et al.
Published: (2020-07-01) -
Infection by the Protozoan Parasite Toxoplasma gondii Inhibits Host MNK1/2-eIF4E Axis to Promote Its Survival
by: Louis-Philippe Leroux, et al.
Published: (2020-09-01) -
Design, Synthesis and Evaluation of Novel Phorbazole C Derivatives as MNK Inhibitors through Virtual High-Throughput Screening
by: Xin Jin, et al.
Published: (2022-06-01) -
The Novel Mnk1/2 Degrader and Apoptosis Inducer VNLG-152 Potently Inhibits TNBC Tumor Growth and Metastasis
by: Senthilmurugan Ramalingam, et al.
Published: (2019-03-01)